ESGIC

Pre-Launch

acetaminophen; butalbital; caffeine

ANDAORALTABLET

Lifecycle

Pre-Launch

Data completeness

4/8 — Partial

ESGIC (acetaminophen; butalbital; caffeine) by Forest Devices is clinical pharmacology this combination drug product is intended as a treatment for tension headache. Approved for minor aches, pains due to: headache sore throat flu toothache the common cold temporarily reduces fever.

Drug data last refreshed 1mo ago

$0.0BPart D

See 2 jobs working on ESGIC →

Mechanism of Action

CLINICAL PHARMACOLOGY This combination drug product is intended as a treatment for tension headache. It consists of a fixed combination of butalbital, acetaminophen and caffeine. The role each component plays in the relief of the complex of symptoms known as tension headache is incompletely…

Worked on ESGIC at Forest Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

ESGIC

Mechanism of Action

Indications (2)

Why This Matters for Your Career